ArticleJournal of endocrinological investigation2026
OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCorticotroph cells produce and secrete adrenocorticotropic hormone (ACTH) from the pro-opiomelanocortin (Pomc) gene. Corticotroph function is controlled by hypothalamic signals through the action of corticotrophin-releasing hormone (CRH) through Nur77 nuclear factor and by feedback repression by glucocorticoids (GC) from adrenal gland acting through the glucocorticoid receptor (GR). Corticotroph adenomas, a pituitary neoplasm, exhibit multiple potential sites of altered signaling, with regulation of the Pomc gene being particularly critical. During differentiation, stem cell markers are silenced, however, some pituitary tumors present expression of progenitor factors. Although some reports show the expression of OCT4 in corticotrophs, its function remains unknow.
methodsWe performed immunoblotting, subcellular fractionation and histochemistry to determine the protein expression of OCT4 in corticothoph cells and in corticotrophic human samples. To study the transcriptional modulation of Pomc promoter by OCT4 and the mechanistic interaction between knowing regulators of ACTH-secreting cells and OCT4, we performed luciferase reporter and immunoprecipitation assays.
resultsOCT4 is expressed in AtT-20 corticotroph cells, in human tumoral samples of patients with an ACTH-secreting tumor, and to a much lesser extent in normal pituitary, showing an expression predominantly nuclear. OCT4 inhibits the transcription of the Pomc gene not by binding to the Pomc promoter, but through its interaction with the transcription factor Nur77. OCT4 also interacts with the negative Pomc regulator GR.
conclusionOur study allows to identify that progenitor marker OCT4 is not only expressed in corticotroph pituitary cells but acts on Pomc regulation through the functional interaction with Nur77 and GR.
Indexed as
Identifiers
42573673What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.